文献速递认知障碍与痴呆脑血管病

临床正常老年人血管风险与β-淀粉样蛋白负荷对认知下降的交互关联:哈佛衰老脑研究结果

Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
PubMed 文献 · JAMA Neurol · 2018-01-01

在哈佛衰老脑研究的223名临床正常老年人中,血管风险(FHS-CVD评分)和β-淀粉样蛋白负荷均与更快的认知下降相关,且两者存在协同交互作用;血管风险在调整Aβ负荷、海马体积、FDG-PET摄取和白质高信号后仍与前瞻性认知下降稳健相关。

要点

  • 血管风险较高与临床正常老年人更快的认知下降相关(β=-0.064)。
  • Aβ负荷较高也与更快的认知下降相关(β=-0.058)。
  • 血管风险与Aβ负荷对认知下降存在协同交互作用(β=-0.040)。

核心结论

  • 在临床正常老年人中,血管风险单独及与Aβ负荷协同地与前瞻性认知下降相关。
  • 血管风险可能在评估临床前阿尔茨海默病的前瞻性认知下降风险时补充影像生物标志物。

研究设计与样本

  • 纵向观察性研究,纳入哈佛衰老脑研究中临床正常的老年人。
  • 参与者需有基线影像数据(FDG-PET、Aβ-PET和磁共振成像)、量化血管风险的基线医疗数据以及至少1次随访神经心理评估。
  • 共纳入223名参与者,其中女性130名(58.3%);平均(SD)年龄73.7(6.0)岁,平均(SD)随访时间3.7(1.2)年。
  • 数据收集始于2010年并正在进行;数据分析针对2010年至2017年间收集的数据。

主要发现

  • 更快的认知下降与较高的FHS-CVD风险评分相关(β=-0.064;95%CI,-0.094至-0.033;P<.001)。
  • 更快的认知下降与较高的Aβ负荷相关(β=-0.058;95%CI,-0.079至-0.037;P<.001)。
  • FHS-CVD风险评分与Aβ负荷和时间的交互作用显著(β=-0.040,95%CI,-0.062至-0.018;P<.001),提示协同效应。
  • 在调整Aβ负荷、海马体积、FDG-PET摄取和白质高信号后,FHS-CVD风险评分仍与前瞻性认知下降稳健相关(β=-0.055;95%CI,-0.086至-0.024;P<.001)。

关键数值与推荐

  • 血管风险使用Framingham心脏研究通用心血管疾病(FHS-CVD)风险评分量化。
  • Aβ负荷使用匹兹堡化合物B PET测量。
  • 认知每年使用临床前阿尔茨海默认知复合量表测量。
  • 模型校正基线年龄、性别、受教育年限和载脂蛋白E ε4状态。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Identifying asymptomatic individuals at high risk of impending cognitive decline because of Alzheimer disease is crucial for successful prevention of dementia. Vascular risk and β-amyloid (Aβ) pathology commonly co-occur in older adults and are significant causes of cognitive impairment. OBJECTIVE: To determine whether vascular risk and Aβ burden act additively or synergistically to promote cognitive decline in clinically normal older adults; and, secondarily, to evaluate the unique influence of vascular risk on prospective cognitive decline beyond that of commonly used imaging biomarkers, including Aβ burden, hippocampal volume, fludeoxyglucose F18-labeled (FDG) positron emission tomography (PET), and white matter hyperintensities, a marker of cerebrovascular disease. DESIGN, SETTING, AND PARTICIPANTS: In this longitudinal observational study, we examined clinically normal older adults from the Harvard Aging Brain Study. Participants were required to have baseline imaging data (FDG-PET, Aβ-PET, and magnetic resonance imaging), baseline medical data to quantify vascular risk, and at least 1 follow-up neuropsychological visit. Data collection began in 2010 and is ongoing. Data analysis was performed on data collected between 2010 and 2017. MAIN OUTCOMES AND MEASURES: Vascular risk was quantified using the Framingham Heart Study general cardiovascular disease (FHS-CVD) risk score. We measured Aβ burden with Pittsburgh Compound-B PET. Cognition was measured annually with the Preclinical Alzheimer Cognitive Composite. Models were corrected for baseline age, sex, years of education, and apolipoprotein E ε4 status. RESULTS: Of the 223 participants, 130 (58.3%) were women. The mean (SD) age was 73.7 (6.0) years, and the mean (SD) follow-up time was 3.7 (1.2) years. Faster cognitive decline was associated with both a higher FHS-CVD risk score (β = -0.064; 95% CI, -0.094 to -0.033; P < .001) and higher Aβ burden (β = -0.058; 95% CI, -0.079 to -0.037; P < .001). The interaction of the FHS-CVD risk score and Aβ burden with time was significant (β = -0.040, 95% CI, -0.062 to -0.018; P < .001), suggesting a synergistic effect. The FHS-CVD risk score remained robustly associated with prospective cognitive decline (β = -0.055; 95% CI, -0.086 to -0.024; P < .001), even after adjustment for Aβ burden, hippocampal volume, FDG-PET uptake, and white matter hyperintensities. CONCLUSIONS AND RELEVANCE: In this study, vascular risk was associated with prospective cognitive decline in clinically normal older adults, both alone and synergistically with Aβ burden. Vascular risk may complement imaging biomarkers in assessing risk of prospective cognitive decline in preclinical Alzheimer disease.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Rabin JS, Schultz AP, Hedden T, et al. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study. JAMA Neurol. 2018. PMID: 29799986. doi:10.1001/jamaneurol.2018.1123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。